Nutex Health Inc. (NASDAQ:NUTX) Sees Large Decline in Short Interest

Nutex Health Inc. (NASDAQ:NUTX) was the target of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 35,700 shares, a drop of 63.7% from the October 15th total of 98,300 shares. Based on an average trading volume of 74,100 shares, the days-to-cover ratio is presently 0.5 days. Currently, 1.2% of the shares of the company are short sold.

Nutex Health Stock Down 12.9 %

NASDAQ NUTX traded down $4.86 on Wednesday, reaching $32.70. The company had a trading volume of 71,666 shares, compared to its average volume of 42,467. The firm has a 50-day moving average of $23.00 and a 200-day moving average of $13.82. Nutex Health has a 1 year low of $4.16 and a 1 year high of $39.48. The firm has a market capitalization of $177.89 million, a PE ratio of -3.57 and a beta of 0.11. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.55.

Insider Transactions at Nutex Health

In other news, CFO Jon Christian Bates acquired 1,350 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was bought at an average cost of $21.46 per share, with a total value of $28,971.00. Following the completion of the purchase, the chief financial officer now directly owns 2,277 shares of the company’s stock, valued at $48,864.42. This represents a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 38.52% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Essex Investment Management Co. LLC acquired a new stake in shares of Nutex Health in the third quarter worth $1,579,000. Thompson Davis & CO. Inc. bought a new position in shares of Nutex Health in the third quarter valued at about $494,000. Finally, International Assets Investment Management LLC bought a new stake in Nutex Health during the 3rd quarter worth about $188,000. Institutional investors own 5.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Benchmark upped their price objective on shares of Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a report on Tuesday. Maxim Group raised their target price on shares of Nutex Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.